Young children, pregnant women, and elderly are the 'targeted'
demographic of flu shot manufacturers, and these individuals also happen
to have the least defense against the elemental neurotoxin mercury.Dr.
Russel Blaylock, a leading neurologist, expains: A recent study
looked at the immune reaction in newborn infants up to the age of one
year who had received the HepB vaccine to see if their immune reaction
differed from adults getting the same vaccine. What they found was that
the infant, even after age one year, did react differently. Their
antibody levels were substantially higher than adults (3-fold higher)
and it remained higher throughout the study.by Anthony Gucciardi http://www.activistpost.com/2011/10/flu-shots-contain-more-than-250-times.html